US 2008/0293791 A1 · VALSARTAN SALTS

Abstract

The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.

Claims10

Dependent claims

A calcium salt of valsartan.

Dependencies are inferred from the claim text.

Facts

Application

12/186,172Filed 5 Aug 2008

Priority

EP 00115556.319 Jul 2000

Published

27 Nov 2008

Term ends

Not estimatedThe source records don’t support an estimate.

Classification19 codes

C07D 257/04
Not condensed with other rings: five-membered rings
A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents

Family

Application10/333,100Continuation · filed 24 Feb 2003

Application11/678,284Continuation · filed 23 Feb 2007

Application12/186,172Continuation

US 2003/0207930 A1Published application

US 2007/0149587 A1Published application

US 8,278,339 B2Related patent

US 2008/0293791 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

12/186,172Filed 5 Aug 2008

Priority

EP 00115556.319 Jul 2000

Published

27 Nov 2008

Term ends

Not estimatedThe source records don’t support an estimate.

Classification19 codes

C07D 257/04
Not condensed with other rings: five-membered rings
A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents

Family

Application10/333,100Continuation · filed 24 Feb 2003

Application11/678,284Continuation · filed 23 Feb 2007

Application12/186,172Continuation

US 2003/0207930 A1Published application

US 2007/0149587 A1Published application

US 8,278,339 B2Related patent

US 2008/0293791 A1This patent

From the US filing history. Foreign family members aren’t listed.

Valsartan salts

Life of this patent

Abstract

Claims10

Valsartan salts

Life of this patent

Abstract

Claims10